misleading statements

NuScale Power faces securities fraud lawsuit over alleged misrepresentations about its ENTRA1 Energy partnership. Stock fell 70% after November 2025 disclosures of $495M payment and $532M loss.

Four major companies face securities fraud lawsuits for misleading investors on AI spending, financial disclosures, and manufacturing claims. Investor filing deadlines approaching.

Plug Power faces securities fraud lawsuit over alleged false statements about DOE loan program. Stock declined after executive departures and suspended loan activities.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and concealed business risks during 2025, following merger collapse and infrastructure delays.

Class action lawsuit filed against Navan alleging IPO disclosure failures on sales and marketing costs. Stock fell 64% from $25 to $9.01 since offering.

Corcept Therapeutics faces class action lawsuit for allegedly misleading statements about relacorilant's clinical evidence. FDA rejected the drug application, causing stock to plummet 50%.

Vistagen faces securities lawsuit over misleading trial disclosures. Investors must nominate lead plaintiff by March 16, 2026 deadline.

Richtech Robotics faces securities lawsuit after overstating Microsoft partnership, causing 30% stock surge followed by 20% decline when Microsoft clarified limited engagement.

Fermi Inc. faces securities lawsuit alleging IPO misrepresentations about AI data center demand and undisclosed tenant risks. Stock fell 59% after primary tenant's $150M funding agreement termination.

REGENXBIO faces class action lawsuit alleging executives made false statements about RGX-111 gene therapy's efficacy and safety, seeking shareholder damages.

PayPal faces securities lawsuit over allegedly false 2027 guidance and checkout platform claims. Investors who bought stock Feb 2025-Feb 2026 may seek compensation.

Rosen Law Firm sues Enphase Energy for allegedly misrepresenting inventory management and overstating financial outlook regarding tax credit impacts.

Oracle faces a securities class action lawsuit over allegedly misleading AI strategy disclosures. Investors must act by April 6, 2026, regarding stock purchased between June-December 2025.

Picard Medical securities lawsuit filing deadline is April 13, 2026. Class action alleges fraudulent stock promotion, insider selling, and artificial trading.

Rosen Law Firm filed a securities class action against Ramaco Resources for allegedly making false statements about its Brook Mine operations between July and October 2025.

Class action lawsuits filed against PomDoctor and Vistagen Therapeutics alleging securities violations. Vistagen's stock fell 80% after failed clinical trial results.

Varonis faces class action lawsuit over allegedly misleading statements about revenue sustainability. Investors have until March 9 to join after stock plunged 48.7%.

Rosen Law Firm seeks lead plaintiff for PomDoctor securities class action by April 7, 2026. Investors alleging losses from fraudulent promotion and misleading statements can apply.

Rosen Law Firm urges Agilon Health investors with losses over $100,000 to join securities class action before March 2026 deadline. Lawsuit alleges false financial guidance.

Corcept Therapeutics faces class action lawsuit over alleged misrepresentation regarding relacorilant drug. FDA rejected the application citing insufficient efficacy data; stock plummeted over 50%.